According to Novanta's latest financial reports the company has a price-to-book ratio of 8.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 8.95 | 6.66% |
2022-12-31 | 8.40 | -30.28% |
2021-12-31 | 12.0 | 38.13% |
2020-12-31 | 8.72 | 17.32% |
2019-12-31 | 7.43 | 24.51% |
2018-12-31 | 5.97 | 7.5% |
2017-12-31 | 5.55 | 98.69% |
2016-12-31 | 2.79 | 46.16% |
2015-12-31 | 1.91 | -19.83% |
2014-12-31 | 2.38 | 51.28% |
2013-12-31 | 1.58 | 22.9% |
2012-12-31 | 1.28 | -21.34% |
2011-12-31 | 1.63 | -17.42% |
2010-12-31 | 1.97 | |
2009-12-31 | N/A | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2003-12-31 | N/A | |
2002-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | -0.8822 | -110.56% | ๐บ๐ธ USA |
Philips PHG | 1.87 | -77.58% | ๐ณ๐ฑ Netherlands |